Dr. Robert L. Steinmetz, MD

Dr. Steinmetz practices at Southern Vitreoretinal Associates, PL in Tallahassee, Florida.

Dr. Steinmetz's NPI, 1194782508, was assigned on April 28, 2006. Dr. Steinmetz graduated from Carver College of Medicine in 1982. Dr. Steinmetz holds Florida license ME63569.

Dr. Steinmetz's primary practice is Southern Vitreoretinal Associates, PL, at 2439 Care Dr, Tallahassee, FL 32308 in Leon County. The practice phone is (850) 942-6700.

Dr. Steinmetz's primary practice is Southern Vitreoretinal Associates, PL in Tallahassee, Florida. Dmand AI also links Dr. Steinmetz to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Steinmetz practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Steinmetz's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Steinmetz is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Steinmetz's licenses on file in 5 states: Florida, California, Georgia, Alabama and Utah.

Dmand AI lists age-related macular degeneration, cataract surgery with lens implant, dry eye, hereditary corneal conditions, hypertensive retinopathy, laser destruction of retinal or choroid lesions, retinal detachment and retinal occlusion among the conditions Dr. Steinmetz treats.

CMS data shows 60,618 Medicare services from Dr. Steinmetz across 17 procedure codes in 2024, for 609 Medicare patients. Medicare paid $2,488,059 for them.

CMS counts 609 Medicare patients who saw Dr. Steinmetz in 2024. The largest group is 75 to 84, with 254 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Steinmetz's median patient age at 74, with 56% women.

In 2024, Dr. Steinmetz wrote 373 Medicare Part D claims for 154 patients. 50% of them were for generic drugs. CMS names the drug for 319 of them, across 2 drugs with 11 or more claims each, at $9,689 in total drug cost. In 2023, CMS named 239 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Steinmetz for performance year 2024, reported as part of a group. Dr. Steinmetz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Steinmetz in 2021. The most frequent topics are Fluorescein Angiography, Fundus Oculi and Visual Acuity. Dr. Steinmetz has published most often in Retina. Dr. Steinmetz's most frequent co-authors are Charles K. Newell, MD, Harry W. Flynn, MD and Mark E. Hammer, MD.

CMS Open Payments shows 87 general payments to Dr. Steinmetz from 14 drug and device companies from 2016 to 2025. Ownership or investment make up the largest share, 94% of the total. US Retina LLC paid the most, $28,154.

Dmand AI lists 3 awards for Dr. Steinmetz, most recently AAO Fellow in 2013.

Dr. Steinmetz graduated from Carver College of Medicine in 1982. Dr. Steinmetz is a member of AAO, AMA, ASRS and The Retina Society.

Dr. Steinmetz is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.